0

Journal Articles

in Drug Therapy
 281-300 of 342 Articles
Original Contribution |  September 17, 2003 FREE
Retrospective Drug Utilization Review, Prescribing Errors, and Clinical Outcomes
Sean Hennessy, PharmD, PhD; Warren B. Bilker, PhD; Lan Zhou, PhD; et al.
JAMA. 2003;290(11):1494-1499. doi:10.1001/jama.290.11.1494.
Original Contribution |  September 17, 2003 FREE
Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme
John S. Markowitz, PharmD; Jennifer L. Donovan, PhD; C. Lindsay DeVane, PharmD; et al.
JAMA. 2003;290(11):1500-1504. doi:10.1001/jama.290.11.1500.
Medical News and Perspectives |  August 27, 2003
Alarm Sounded on Fake, Tainted Drugs
JAMA. 2003;290(8):1015-1016. doi:10.1001/jama.290.8.1015.
Health Agencies Update |  July 16, 2003
Medical Illustrations on Display
JAMA. 2003;290(3):324. doi:10.1001/jama.290.3.324-a.
Capitol Health Call |  July 02, 2003
Medicare Bill Uncertain
JAMA. 2003;290(1):29. doi:10.1001/jama.290.1.29-a.
From the Centers for Disease Control and Prevention |  May 07, 2003 FREE
2003 Conference on Antimicrobial Resistance
JAMA. 2003;289(17):2206. doi:10.1001/jama.289.17.2313.
Original Contribution |  April 02, 2003 FREE
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
David N. Juurlink, MD, FRCPC; Muhammad Mamdani, PharmD, MPH; Alexander Kopp; et al.
JAMA. 2003;289(13):1652-1658. doi:10.1001/jama.289.13.1652.
Original Contribution |  March 05, 2003 FREE
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Jerry H. Gurwitz, MD; Terry S. Field, DSc; Leslie R. Harrold, MD, MPH; et al.
JAMA. 2003;289(9):1107-1116. doi:10.1001/jama.289.9.1107.
Medical News and Perspectives |  February 19, 2003
Survey Suggesting That Prescription Drug Ads Help Public Is Met With Skepticism
JAMA. 2003;289(7):827-828. doi:10.1001/jama.289.7.827.
Commentary |  January 22, 2003
Direct-to-Consumer Advertising and Shared Liability for Pharmaceutical Manufacturers
Michelle M. Mello, JD, PhD; Meredith Rosenthal, PhD; Peter J. Neumann, ScD
JAMA. 2003;289(4):477-481. doi:10.1001/jama.289.4.477.
Original Contribution |  October 09, 2002 FREE
Employer Drug Benefit Plans and Spending on Prescription Drugs
Geoffrey F. Joyce, PhD; José J. Escarce, MD, PhD; Matthew D. Solomon, MA; et al.
JAMA. 2002;288(14):1733-1739. doi:10.1001/jama.288.14.1733.
Original Contribution |  July 10, 2002 FREE
Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons
Robert M. Grant, MD, MPH; Frederick M. Hecht, MD; Maria Warmerdam, BS; et al.
JAMA. 2002;288(2):181-188. doi:10.1001/jama.288.2.181.
Clinical Crossroads Update |  June 26, 2002
A 40-Year-Old Woman Who Noticed a Medication Error, 1 Year Later
Anne-Marie J. Audet, MD, MSc; Erin E. Hartman, MS
JAMA. 2002;287(24):3258. doi:10.1001/jama.287.24.3258.
Editorial |  June 19, 2002
Dynamics of Antibiotic Prescribing for Children
Michael E. Pichichero, MD
JAMA. 2002;287(23):3133-3135. doi:10.1001/jama.287.23.3133.
Original Contribution |  June 19, 2002 FREE
Trends in Antimicrobial Prescribing Rates for Children and Adolescents
Linda F. McCaig, MPH; Richard E. Besser, MD; James M. Hughes, MD
JAMA. 2002;287(23):3096-3102. doi:10.1001/jama.287.23.3096.
Original Contribution |  June 19, 2002 FREE
Changes in Antibiotic Prescribing for Children After a Community-wide Campaign
Joseph F. Perz, DrPH; Allen S. Craig, MD; Christopher S. Coffey, PhD; et al.
JAMA. 2002;287(23):3103-3109. doi:10.1001/jama.287.23.3103.
Editorial |  May 01, 2002
Safety of Newly Approved Drugs:  Implications for Prescribing
Robert J. Temple, MD; Martin H. Himmel, MD, MPH
JAMA. 2002;287(17):2273-2275. doi:10.1001/jama.287.17.2273.
Original Contribution |  February 06, 2002 FREE
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Niteesh K. Choudhry, MD, FRCPC; Henry Thomas Stelfox, MD, FRCPC; Allan S. Detsky, MD, PhD, FRCPC
JAMA. 2002;287(5):612-617. doi:10.1001/jama.287.5.612.
Special Communication |  February 06, 2002
Nonspecific Medication Side Effects and the Nocebo Phenomenon
Arthur J. Barsky, MD; Ralph Saintfort, MD; Malcolm P. Rogers, MD; et al.
JAMA. 2002;287(5):622-627. doi:10.1001/jama.287.5.622.
Medical News and Perspectives |  December 26, 2001
Annals of Internal Medicine
JAMA. 2001;286(24):3065-3066. doi:10.1001/jama.286.24.3065.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Original Investigation  |  February 4, 2013
Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortality:  The National Institutes of Health–AARP Diet and Health Study
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems